Akso Health Group (NASDAQ:AHG – Get Free Report) and Relx (NYSE:RELX – Get Free Report) are both retail/wholesale companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, profitability, risk and valuation.
Risk and Volatility
Akso Health Group has a beta of 0.21, meaning that its stock price is 79% less volatile than the S&P 500. Comparatively, Relx has a beta of 0.89, meaning that its stock price is 11% less volatile than the S&P 500.
Valuation and Earnings
This table compares Akso Health Group and Relx”s gross revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Akso Health Group | $2.41 million | 74.24 | -$9.46 million | N/A | N/A |
Relx | $9.30 billion | 9.10 | $2.22 billion | N/A | N/A |
Analyst Ratings
This is a breakdown of current ratings and target prices for Akso Health Group and Relx, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Akso Health Group | 0 | 0 | 0 | 0 | 0.00 |
Relx | 0 | 1 | 0 | 1 | 3.00 |
Profitability
This table compares Akso Health Group and Relx’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Akso Health Group | N/A | N/A | N/A |
Relx | N/A | N/A | N/A |
Institutional & Insider Ownership
1.2% of Akso Health Group shares are held by institutional investors. Comparatively, 15.0% of Relx shares are held by institutional investors. 0.0% of Relx shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Summary
Relx beats Akso Health Group on 7 of the 8 factors compared between the two stocks.
About Akso Health Group
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.
About Relx
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides information and data sets that help researchers and healthcare professionals to advance science and health outcomes. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and complete transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
Receive News & Ratings for Akso Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akso Health Group and related companies with MarketBeat.com's FREE daily email newsletter.